GBGil Belofsky

Gil Belofsky

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Gil Belofsky has a total of 7 co-authors. Here are the top co-authors by number of shared publications:

  • Roberto Carreno

    2 shared publications
  • Anthony R. Ball

    Gliese 623B, Lowell, MA 01852, USA

    1 shared publication
  • David T. John

    1 shared publication
  • Gabriele Casadei

    Department of Chemistry and Biochemistry, The University of Tulsa, Tulsa, Oklahoma 74101, Department of Biology, Northeastern University, Boston, Massachusetts 02115, Department of Food Science, School of Veterinary Medicine, University of Teramo, Teramo, Italy, 64100, Department of Dermatology, Harvard Medical School, Wellman Laboratories of Photomedicine, Massachusetts General Hospital, Boston, Massachusetts 02114

    1 shared publication
  • George P. Tegos

    Department of Chemistry and Biochemistry, The University of Tulsa, Tulsa, Oklahoma 74101, Department of Biology, Northeastern University, Boston, Massachusetts 02115, Department of Food Science, School of Veterinary Medicine, University of Teramo, Teramo, Italy, 64100, Department of Dermatology, Harvard Medical School, Wellman Laboratories of Photomedicine, Massachusetts General Hospital, Boston, Massachusetts 02114

    1 shared publication
  • Kim Lewis

    Department of Chemistry and Biochemistry, The University of Tulsa, Tulsa, Oklahoma 74101, Department of Biology, Northeastern University, Boston, Massachusetts 02115, Department of Food Science, School of Veterinary Medicine, University of Teramo, Teramo, Italy, 64100, Department of Dermatology, Harvard Medical School, Wellman Laboratories of Photomedicine, Massachusetts General Hospital, Boston, Massachusetts 02114

    1 shared publication

Latest Publications

  • Activity of Isoflavans ofDalea aurea(Fabaceae) against the Opportunistic AmebaNaegleria fowleri

    by Gil Belofsky, Roberto Carreno, Shannon M. Goswick, David T. John

    One new and one known isoflavan, 3S(+)-7-methoxymanuifolin K (1) and manuifolin K (2), respectively, were isolated from methanolic extracts of Dalea aurea (Fabaceae). Isoflavans 1 and 2 exhibited significant in vitro activity against the ameba Naegleria fowleri, an organism responsible for an infrequent but rapidly fatal form of primary amebic meningoencephalitis (PAM). At concentrations of 30 μM, both 1 and 2 caused growth inhibition of N. fowleri at a level comparable to amphotericin B (at 0.1 μM), the currently preferred treatment for this disease. Over a seven-day growth period, 1 and 2 (30 μM) exhibited superior growth inhibition of N. fowleri than amphotericin B after day 4. Isoflavan 2 was evaluated in a mouse model of PAM at a dose of 25 mg/kg/day for five days. While amphotericin B (2.5 mg/kg/day) offered 12.5 % protection of the mice, compound 2 did not protect the mice from PAM infection compared to controls.


  • Metabolites of the “Smoke Tree”, Dalea spinosa, Potentiate Antibiotic Activity against Multidrug-Resistant Staphylococcus aureus

    by Gil Belofsky, Roberto Carreno, Kim Lewis, Anthony Ball, Gabriele Casadei, George P. Tegos

    Two new 2-arylbenzofuran aldehydes (1 and 2) and three known phenolic compounds (3−5) were isolated from organic extracts of Dalea spinosa. These compounds were evaluated for their intrinsic antimicrobial activity and their ability to perform as multidrug-resistance inhibitors by potentiating the activity of known antimicrobials against a variety of pathogenic microorganisms. Compound 1 and its acetate derivative 6 exhibited no direct antimicrobial activity but enhanced the effect of the weak plant antimicrobial berberine when tested against Staphylococcus aureus. Additional potentiation assays with S. aureus overexpression and knockout isogenic efflux mutants for the NorA pump were done in order to assess whether the potentiating effects were associated with inhibition of this known pump mechanism.